Ganga Pharma Peer Comparison

BSE: 539680

₹12.50

₹0.50 (4.17%)

As on 08-Sep-2026IST

Market cap

₹7 Cr

Revenue (TTM)

₹3 Cr

P/E Ratio

73.2

P/B Ratio

0.9

Div. Yield

0 %

Edit

	Ganga Pharma	Jeena Sikho	Sat Kartar Life	Kerala Ayurveda	Vaidya Sane Ayur
Market cap (₹ Cr)	7	6,414	260	214	180
Revenue (₹ Cr)	3	851	201	136	90
Net Profit (₹ Cr)	0.08	236.31	17.10	-26.43	7.15
Net Margin (%)	2.57	27.06	8.42	-18.78	7.80
RoE (%)	1.22	57.63	28.72	-319.95	13.66
Price to Earnings	73.16	27.12	15.20	--	20.06
Price-To-Book	0.92	12.10	3.80	-10.62	2.88

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Ganga Pharma	Jeena Sikho	Sat Kartar Life	Kerala Ayurveda	Vaidya Sane Ayur
Operating Revenue	2.64	469.07	162.92	120.33	89.85
Total Income	3.07	475.81	163.68	122.53	91.70
Total Expenditure	2.75	328.47	148.69	125.33	76.22
EBITDA	-0.12	140.60	14.23	-5.00	13.63
Depreciation	0.05	29.11	1.30	4.98	4.16
EBIT	-0.16	111.50	12.93	-9.97	9.47
Interest	0.18	10.65	0.54	4.46	0.23
Other Income	0.44	6.74	0.76	2.19	1.86
Exceptional Items	--	--	--	--	-1.20
Profit before Tax	0.09	107.58	13.15	-12.24	9.90
Provision for Tax	0.02	27.63	3.34	1.72	2.74
Profit after Tax	0.08	79.94	9.82	-13.96	7.15

Liabilities (₹ Cr)

	Ganga Pharma	Jeena Sikho	Sat Kartar Life	Kerala Ayurveda	Vaidya Sane Ayur
Shareholder's Funds	7.13	256.34	51.50	9.49	62.54
Minority Interest	--	--	--	3.40	0.00
Non-Current Liabilities	0.24	83.41	1.28	23.12	2.95
Current Liabilities	1.60	73.35	11.34	87.98	11.22
Total Liabilities	8.97	418.95	64.83	128.76	76.71

Assets (₹ Cr)

	Ganga Pharma	Jeena Sikho	Sat Kartar Life	Kerala Ayurveda	Vaidya Sane Ayur
Non-Current Assets	2.11	278.13	8.37	83.22	46.42
Current Assets	6.87	134.98	55.75	40.67	30.28
Total Assets	8.97	418.95	64.83	128.76	76.71
Total Debt*	1.42	10.74	5.92	65.97	1.46
Net Current Assets	5.26	61.63	44.41	-47.31	19.06
Contingent Liabilities	--	5.08	--	--	3.49

Cashflow (₹ Cr)

	Ganga Pharma	Jeena Sikho	Sat Kartar Life	Kerala Ayurveda	Vaidya Sane Ayur
Cash From Operating Activities	-0.58	84.50	-5.07	4.83	10.60
Cash Flow from Investing Activities	1.18	-64.48	-0.31	-14.77	-10.08
Cash from Financing Activities	-0.33	-22.45	33.56	-9.48	-0.54
Net Cash Inflow / Outflow	0.27	-2.43	28.18	-19.42	-0.01

Ratios

Profitability Ratios

	Ganga Pharma	Jeena Sikho	Sat Kartar Life	Kerala Ayurveda	Vaidya Sane Ayur
ROCE (%)	3.22	60.06	23.84	-8.94	16.70
ROE (%)	1.22	41.94	19.06	-86.43	13.66
ROA (%)	0.90	28.36	15.31	-10.55	9.78
EBIT Margin (%)	12.12	31.41	9.20	-2.33	17.23
Net Margin (%)	2.57	16.80	6.00	-11.39	7.80
Cash Profit Margin (%)	4.76	23.25	6.82	-7.15	12.59

Growth Ratios

	Ganga Pharma	Jeena Sikho	Sat Kartar Life	Kerala Ayurveda	Vaidya Sane Ayur
Revenue Growth (%)	-3.60	129.09	0.00	11.57	-9.55
EBIT Growth (%)	7.58	--	--	-138.57	147.29
Net Profit Growth (%)	69.52	138.48	0.00	-1,517.68	259.44
EPS Growth (%)	69.50	136.63	0.00	-840.72	260.17
Book Value Growth (%)	1.23	103.06	0.00	-88.76	48.29

Valuation Ratios

	Ganga Pharma	Jeena Sikho	Sat Kartar Life	Kerala Ayurveda	Vaidya Sane Ayur
Price / Earnings	62.24	13.58	24.39	0.00	13.81
Price / Book Value	0.76	21.24	4.65	129.43	1.58
Dividend Yield (%)	0.00	0.25	0.46	0.00	0.00
EV/EBITDA	18.89	36.75	14.32	-173.00	6.31
Market Cap (₹ Cr)	4.92	5,426.22	239.40	422.59	98.58

Solvency Ratios

	Ganga Pharma	Jeena Sikho	Sat Kartar Life	Kerala Ayurveda	Vaidya Sane Ayur
Debt to Equity	0.22	0.04	0.11	20.21	0.02
Short term debt to equity ratio	0.14	0.04	0.08	4.86	0.02
Current Ratio	4.28	1.84	4.92	0.46	2.70
Quick Ratio	3.55	1.68	4.51	0.32	2.36
Interest Coverage	1.53	11.10	25.38	-1.75	44.76

Operating Efficiency Ratios

	Ganga Pharma	Jeena Sikho	Sat Kartar Life	Kerala Ayurveda	Vaidya Sane Ayur
Debtors to sales (%)	34.53	18.11	3.67	16.04	8.39
Asset Turnover	0.30	1.66	2.54	0.95	1.23
Receivable days	126.89	41.64	13.39	51.00	27.60
Inventory Days	167.70	6.09	10.22	41.35	15.99
Payable days	57.59	73.44	169.52	128.93	152.09
Cash Conversion Cycle	237.00	-25.71	-145.91	-36.58	-108.51

Annual
Quarterly